MedCoral 啟動全球「換骨」革命

MedCoral Sparks a Global Bone Graft Revolution 2025年12月20日，台北萬豪酒店見證了一個歷史時刻。曾橫掃全球三大發明展金牌的「仆派海洋生技（Popeye Marine Biotechnology）」，正式發表了 MedCoral 品牌，向世界宣告：人工培植珊瑚量化技術已全面成熟。這不只是技術的突破，更是執行長沈儀仁多年前夢想的具現化——用永續材料造福人類，Let's make life better!

On December 20, 2025, the Taipei Marriott Hotel bore witness to a historic milestone. Popeye Marine Biotechnology, a triple-gold medalist at major international invention exhibitions, officially launched its "MedCoral" brand. This event signals that mass-production technology for lab-grown coral has reached its peak. More than just a technical breakthrough, it is the realization of CEO Yi-Jen Shen’s long-held dream: utilizing sustainable materials to enhance human well-being. Let's make life better!

仆派海洋生技 執行長 沈儀仁 Popeye Marine Biotechnology CEO Yi-Jen Shen

從海洋到診間：ESG 永續骨材的奇蹟

From Ocean to Clinic: The Miracle of ESG-Sustainable Bone Material

MedCoral 的核心優勢在於其「唯一性」與「永續性」。傳統珊瑚採集會破壞生態，但仆派海洋生技透過獨家專利的人工培植技術，在珊瑚培育技術中心「種」出具備高度生物相容性的珊瑚骨材。

The core advantage of MedCoral lies in its uniqueness and sustainability. While traditional coral harvesting damages marine ecosystems, Popeye Marine Biotechnology utilizes exclusive patented cultivation technology to "grow" coral bone grafts with superior biocompatibility in controlled environments at the Coral Cultivation Technology Center.

• 國際認證

  Global Certification:

  
  

  已取得台灣TFDA高階醫材認證, 美國FDA認證中, 擁有包含美、台、日、中、越、印尼等多國專利。

  
  

  MedCoral has obtained Taiwan TFDA certification for high-end medical devices, with U.S. FDA clearance currently in progress. Our technology holds patents across multiple countries, including the U.S., Taiwan, Japan, China, Vietnam, and Indonesia.

  
  

• 臨床實證

  Clinical Evidence:

  
  

  承襲國際期刊數萬例臨床文獻，

  MedCoral 已成為骨科與牙科醫師的新寵。

  
  

  Building on tens of thousands of documented clinical cases, MedCoral is becoming the preferred choice for orthopedic and dental surgeons worldwide.

未來視野：3D 列印骨骼與全球骨骼銀行

Future Vision: 3D-Printed Bones and Global Bone Banks

除了目前的骨粉應用，沈執行長更揭示了改變醫療體系的宏大藍圖。這項技術對未來醫療系統的影響力將是顛覆性的：

Beyond current applications, CEO Yi-Jen Shen revealed a grand blueprint that will transform healthcare systems. The impact of this technology on the future of medicine is revolutionary:

• 3D 列印骨骼與細胞支架

  3D-Printed Bones & Cell Scaffolds:

  
  

  透過國際合作，MedCoral 正在研發客製化的 3D 列印骨骼，能精準修復人體缺損，降低傳統人工骨材的排斥風險。

  
  

  Through international R&D collaborations, MedCoral is developing customized 3D-printed bone structures that precisely repair human defects while minimizing the risks associated with traditional artificial materials.

• 全球骨骼銀行

  Global Bone Bank:

  
  

  仆派的目標是打造「全球骨骼銀行製造中心」，讓穩定、高品質的永續骨材像半導體晶片一樣，供應全世界的醫療需求。

  
  

  Popeye aims to establish a "Global Bone Bank Manufacturing Center," ensuring that stable, high-quality sustainable bone material can be supplied to clinics worldwide, much like Taiwan's semiconductor industry supports global tech.

下一個生技護國神山

The Next Biotech "Guardian Mountain"

多年來，執行長的夢想不斷支撐著公司突破技術瓶頸。隨著 MedCoral 的問世，台灣生技產業有望繼半導體之後，成為另一座「護國神山」。當天然、永續的材料成為醫療主流，我們看見的不只是兆元產值，更是人類生命品質的全面提升。

For years, the CEO’s vision has pushed the company to overcome technical barriers. With the launch of MedCoral, Taiwan's biotech sector is poised to become the next "Guardian Mountain". As natural, ESG-sustainable materials become the clinical standard, we are seeing more than just a multi-billion dollar market—we are witnessing a total upgrade in the quality of human life.